Home >> Signaling Pathways >> MAPK Signaling >> MAPKAPK2 (MK2)

MAPKAPK2 (MK2)

MAP kinase-activated protein kinase 2 (MAPKAPK2) is an enzyme that in humans is encoded by the MAPKAPK2 gene. MAPKAP kinase-2 (MK2) is originally identified by its phosphorylation of glycogen synthase at serine-7 and the corresponding serine in a peptide (GS peptide-1) modelled after the N-terminus of glycogen synthase.

MAPKAP kinase-2 is a novel protein kinase activated by mitogen-activated protein kinase. This MAP kinase activated protein kinase, termed MAPKAP kinase-2, is distinguished from S6 kinase-II (MAPKAP kinase-1) by its response to inhibitors, lack of phosphorylation of S6 peptides and amino acid sequence.

Products for  MAPKAPK2 (MK2)

  1. Cat.No. 产品名称 Information
  2. GC64580 MMI-0100 MMI-0100 是一种细胞渗透性肽抑制剂,抑制丝裂原活化蛋白激酶活化蛋白激酶 II (MK2)。MMI-0100 在体内外减少内膜增生。MMI-0100 抑制 IL-6 表达而不影响 IL-8 表达。MMI-0100 抑制纤维化过程,例如静脉移植疾病。
  3. GC63441 CC-99677 CC-99677 是一种有效的、共价的、不可逆的丝裂原活化蛋白 (MAP) 激酶活化蛋白激酶 -2 (MK2)通路抑制剂,在生化(IC50=156.3 nM) 和细胞基础检测 (EC50=89 nM) 中均有作用。CC-99677 来自专利 WO2020236636,化合物 1。
  4. GC63425 Zunsemetinib

    ATI-450; CDD-450

    Zunsemetinib (CDD-450) 是一种具有口服活性的 p38α 丝裂原激活蛋白激酶激活蛋白激酶2 (MK2)通路抑制剂。Zunsemetinib 可用于免疫炎症性疾病的研究。
  5. GC61819 MK2-IN-3 MK2 Inhibitor III (MK2-IN-3) is an ATP-competitive MK2 (MAPKAP-K2) inhibitor with an IC50 value of 8.5 nM.
  6. GC44211 MK2 Inhibitor III A potent, cell-permeable inhibitor of MK2
  7. GC33142 MK2-IN-1 (MK2 Inhibitor) MK2-IN-1 (MK2 Inhibitor) 是一种有效的、选择性的 MAPKAPK2(MK2) 抑制剂 (IC50=0.11 uM),具有非 ATP 竞争性结合模式。
  8. GC16723 MK2 Inhibitor IV

    MK 25

    A highly selective MAPKAPK2 (MK2) inhibitor
  9. GC11180 CMPD-1

    CMPD 1

    A substrate-selective p38α MAPK inhibitor
  10. GC14645 PF-3644022 PF-3644022 是一种有效的、选择性的、具有口服活性和 ATP 竞争性的 MAPKAPK2 (MK2) 抑制剂,IC50 为 5.2 nM,Ki 为 3 nM。

9 Item(s)

per page

Set Descending Direction